Children's Oncology Group

Children's Oncology Group
Name	Children's Oncology Group
Abbreviation	COG
Formation	2000
Type	Pediatric oncology cooperative group
Headquarters	Austin, Texas
Region served	International
Membership	Hospitals, research centers, clinicians

Children's Oncology Group is a pediatric cancer clinical trials consortium that brings together hospitals, research institutions, and clinicians to study childhood cancers and develop treatments. Founded through a merger of legacy cooperative groups, it conducts multicenter trials across North America and collaborates with international partners to evaluate therapies for leukemias, solid tumors, and rare pediatric malignancies. The group coordinates protocol development, data management, and translational research to improve survival and quality of life for children treated at member institutions.

History

The organization's roots trace to mergers among legacy cooperative groups such as Children's Cancer Group, Pediatric Oncology Group, National Wilms Tumor Study Group, and Intergroup Rhabdomyosarcoma Study Group, consolidating pediatric oncology trials infrastructure around 2000. Early milestones include integrating trial networks that had origins in archives from National Cancer Institute cooperative programs and harmonizing protocols influenced by landmark studies like those at St. Jude Children's Research Hospital and Dana-Farber Cancer Institute. Over subsequent decades, collaborative work with entities such as American Society of Clinical Oncology, European Society for Paediatric Oncology, Institute of Cancer Research, and national agencies including Health Resources and Services Administration shaped trial governance and cross-border partnerships. Major historical protocols addressed diseases linked to groups formerly centered at Memorial Sloan Kettering Cancer Center, Fred Hutchinson Cancer Center, and Children's Hospital of Philadelphia.

Organization and Governance

The group's governance model features committees and leadership drawn from institutional members including Boston Children's Hospital, Seattle Children's Hospital, Texas Children's Hospital, and Hospital for Sick Children (Toronto). Executive structures incorporate scientific steering committees, protocol review panels, and ethics oversight with representation from centers like Cincinnati Children's Hospital Medical Center, Johns Hopkins Hospital, University of California, San Francisco Medical Center, and Mayo Clinic. Regulatory compliance interacts with agencies such as the Food and Drug Administration, European Medicines Agency, and national regulatory authorities in collaborations with sponsors including National Institutes of Health and philanthropic partners like St. Baldrick's Foundation. Data coordination centers and biostatistics cores often work with university partners such as University of Michigan, University of Pennsylvania, and Columbia University.

Research Programs and Clinical Trials

Research programs span acute lymphoblastic leukemia protocols influenced by earlier trials at Memorial Sloan Kettering Cancer Center and Seattle Children's Hospital, neuroblastoma studies in collaboration with Children's Hospital of Philadelphia and Dana-Farber Cancer Institute, and sarcoma trials building on work from MD Anderson Cancer Center and Vanderbilt University Medical Center. Trials incorporate translational science with laboratories at St. Jude Children's Research Hospital, Fred Hutchinson Cancer Center, and biorepositories partnering with The Broad Institute and National Cancer Institute. Cooperative studies evaluate chemotherapy regimens, immunotherapy approaches tested in tandem with National Institutes of Health investigators, and radiation protocols developed with radiation oncology groups at Massachusetts General Hospital and UCLA Medical Center. Pediatric survivorship and late effects research draws expertise from centers such as Children's National Hospital and Seattle Children's Hospital while pharmacology and dosing studies have engaged researchers from University of Texas Southwestern Medical Center and Harvard Medical School.

Membership and Collaborations

Membership comprises pediatric oncology divisions, cancer centers, and affiliated hospitals including Rady Children's Hospital, Boston Medical Center, Children's Healthcare of Atlanta, Rush University Medical Center, and international institutions like Great Ormond Street Hospital and SickKids Toronto. Collaborative networks extend to disease-specific foundations such as Alex's Lemonade Stand Foundation and The Michael J. Fox Foundation where scientific overlaps exist, and to consortia including International Society of Paediatric Oncology and European Organisation for Research and Treatment of Cancer for joint trials. Industry partnerships with pharmaceutical companies and biotechnology firms collaborate on investigational agents alongside academic partners like Yale School of Medicine and Northwestern Memorial Hospital. Training and education initiatives coordinate with professional societies including American Academy of Pediatrics and Society for Pediatric Oncology Nursing.

Impact and Outcomes

The consortium's trials have contributed to improvements in survival for conditions such as acute lymphoblastic leukemia, Wilms tumor, and Hodgkin lymphoma through protocols informed by research at St. Jude Children's Research Hospital, Dana-Farber Cancer Institute, and Memorial Sloan Kettering Cancer Center. Outcomes research and long-term follow-up studies conducted with partners like National Cancer Institute and Centers for Disease Control and Prevention have characterized late effects, fertility outcomes, and secondary malignancy risk, influencing guidelines promulgated by organizations such as American Society of Clinical Oncology. Quality-of-life and patient-reported outcome measures were developed in collaboration with academic centers including University of California, San Diego, University of Minnesota, and Vanderbilt University Medical Center.

Funding and Grants

Funding sources include federal grants from agencies like the National Institutes of Health and programmatic support from the National Cancer Institute, supplemented by philanthropic contributions from charities such as St. Baldrick's Foundation, Alex's Lemonade Stand Foundation, and private donors tied to institutions like Children's Hospital Los Angeles. Research contracts and cooperative agreements involve partnerships with industry sponsors and grants administered through university technology transfer offices at institutions such as Harvard University, Johns Hopkins University, and University of Pennsylvania. Additional support for infrastructure and biobanking has come from foundations and international grant programs associated with Wellcome Trust and other global funders.

Category:Pediatric oncology